108 related articles for article (PubMed ID: 8573197)
1. Species-specific differences in taxol transport and cytotoxicity against human and rodent tumor cells. Evidence for an alternate transport system.
Parekh H; Simpkins H
Biochem Pharmacol; 1996 Feb; 51(3):301-11. PubMed ID: 8573197
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance phenotype and paclitaxel (Taxol) sensitivity in human renal carcinoma cell lines of different histologic types.
Reinecke P; Schmitz M; Schneider EM; Gabbert HE; Gerharz CD
Cancer Invest; 2000; 18(7):614-25. PubMed ID: 11036469
[TBL] [Abstract][Full Text] [Related]
3. Acquisition of taxol resistance via P-glycoprotein- and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells.
Parekh H; Wiesen K; Simpkins H
Biochem Pharmacol; 1997 Feb; 53(4):461-70. PubMed ID: 9105396
[TBL] [Abstract][Full Text] [Related]
4. A functional assay for quantitation of the apparent affinities of ligands of P-glycoprotein in Caco-2 cells.
Gao J; Murase O; Schowen RL; Aubé J; Borchardt RT
Pharm Res; 2001 Feb; 18(2):171-6. PubMed ID: 11405287
[TBL] [Abstract][Full Text] [Related]
5. Taxol Analogues Exhibit Differential Effects on Photoaffinity Labeling of β-Tubulin and the Multidrug Resistance Associated P-Glycoprotein.
Yang CH; Wang C; Ojima I; Horwitz SB
J Nat Prod; 2018 Mar; 81(3):600-606. PubMed ID: 29517223
[TBL] [Abstract][Full Text] [Related]
6. The transport and binding of taxol.
Parekh H; Simpkins H
Gen Pharmacol; 1997 Aug; 29(2):167-72. PubMed ID: 9251895
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a taxol-resistant human small-cell lung cancer cell line.
Ohta S; Nishio K; Kubota N; Ohmori T; Funayama Y; Ohira T; Nakajima H; Adachi M; Saijo N
Jpn J Cancer Res; 1994 Mar; 85(3):290-7. PubMed ID: 7514586
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of a Fluorescent Analogue of Paclitaxel That Selectively Binds Microtubules and Sensitively Detects Efflux by P-Glycoprotein.
Lee MM; Gao Z; Peterson BR
Angew Chem Int Ed Engl; 2017 Jun; 56(24):6927-6931. PubMed ID: 28485901
[TBL] [Abstract][Full Text] [Related]
9. Novel mechanism of resistance to paclitaxel (Taxol) in human K562 leukemia cells by combined selection with PSC 833.
Jaffrézou JP; Dumontet C; Derry WB; Durán G; Chen KG; Tsuchiya E; Wilson L; Jordan MA; Sikic BI
Oncol Res; 1995; 7(10-11):517-27. PubMed ID: 8866664
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide.
Nielsen D; Maare C; Eriksen J; Litman T; Friche E; Skovsgaard T
Biochem Pharmacol; 2000 Aug; 60(3):353-61. PubMed ID: 10856430
[TBL] [Abstract][Full Text] [Related]
11. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution.
Breuninger LM; Paul S; Gaughan K; Miki T; Chan A; Aaronson SA; Kruh GD
Cancer Res; 1995 Nov; 55(22):5342-7. PubMed ID: 7585598
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH
Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.
Liu B; Staren ED; Iwamura T; Appert HE; Howard JM
J Surg Res; 2001 Aug; 99(2):179-86. PubMed ID: 11469885
[TBL] [Abstract][Full Text] [Related]
14. Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line.
Enokida H; Gotanda T; Oku S; Imazono Y; Kubo H; Hanada T; Suzuki S; Inomata K; Kishiye T; Tahara Y; Nishiyama K; Nakagawa M
Jpn J Cancer Res; 2002 Sep; 93(9):1037-46. PubMed ID: 12359058
[TBL] [Abstract][Full Text] [Related]
15. Effects of tubulin-inhibiting agents in human lung and breast cancer cell lines with different multidrug resistance phenotypes.
van Ark-Otte J; Samelis G; Rubio G; Lopez Saez JB; Pinedo HM; Giaccone G
Oncol Rep; 1998; 5(1):249-55. PubMed ID: 9458331
[TBL] [Abstract][Full Text] [Related]
16. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.
Kavallaris M; Kuo DY; Burkhart CA; Regl DL; Norris MD; Haber M; Horwitz SB
J Clin Invest; 1997 Sep; 100(5):1282-93. PubMed ID: 9276747
[TBL] [Abstract][Full Text] [Related]
17. Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells.
Ranganathan S; Benetatos CA; Colarusso PJ; Dexter DW; Hudes GR
Br J Cancer; 1998 Feb; 77(4):562-6. PubMed ID: 9484812
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells.
Yang CP; Galbiati F; Volonte D; Horwitz SB; Lisanti MP
FEBS Lett; 1998 Nov; 439(3):368-72. PubMed ID: 9845355
[TBL] [Abstract][Full Text] [Related]
19. A unique interaction between polyamine and multidrug resistance (P-glycoprotein) transporters in cultured Chinese hamster ovary cells transfected with mouse mdr-1 gene.
Aziz SM; Worthen DR; Yatin M; Ain KB; Crooks PA
Biochem Pharmacol; 1998 Jul; 56(2):181-7. PubMed ID: 9698071
[TBL] [Abstract][Full Text] [Related]
20. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
Bai Z; Gao M; Zhang H; Guan Q; Xu J; Li Y; Qi H; Li Z; Zuo D; Zhang W; Wu Y
Cancer Lett; 2017 Aug; 402():81-92. PubMed ID: 28576750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
